XML 62 R48.htm IDEA: XBRL DOCUMENT v3.4.0.3
Financial Instruments - Balance Sheet Grouping (Detail) - USD ($)
$ in Millions
Apr. 03, 2016
Dec. 31, 2015
Assets    
Selected financial assets $ 33,705 $ 38,157
Liabilities    
Selected financial liabilities 41,122 40,608
Cash and Cash Equivalents [Member]    
Assets    
Selected financial assets 809 978
Short-term Investments [Member]    
Assets    
Selected financial assets 16,882 19,649
Long-term Investments [Member]    
Assets    
Selected financial assets 14,146 15,999
Other Current Assets [Member]    
Assets    
Selected financial assets [1] 390 587
Other Noncurrent Assets [Member]    
Assets    
Selected financial assets [2] 1,478 944
Short-Term Borrowings, Including Current Portion of Long-Term Debt [Member]    
Liabilities    
Selected financial liabilities [3] 11,546 10,159
Other Current Liabilities [Member]    
Liabilities    
Selected financial liabilities [4] 862 645
Long-term debt [Member]    
Liabilities    
Selected financial liabilities [3] 27,824 28,740
Other Noncurrent Liabilities [Member]    
Liabilities    
Selected financial liabilities [5] $ 890 $ 1,064
[1] As of April 3, 2016, derivative instruments at fair value include interest rate swaps ($5 million), foreign currency swaps ($62 million) and foreign currency forward-exchange contracts ($323 million) and, as of December 31, 2015, include interest rate swaps ($2 million), foreign currency swaps ($46 million) and foreign currency forward-exchange contracts ($538 million).
[2] As of April 3, 2016, derivative instruments at fair value include interest rate swaps ($1,428 million), foreign currency swaps ($41 million) and foreign currency forward-exchange contracts ($9 million) and, as of December 31, 2015, include interest rate swaps ($835 million), foreign currency swaps ($89 million) and foreign currency forward-exchange contracts ($20 million).
[3] We adopted a new standard as of January 1, 2016 that changed the presentation of debt issuance costs related to a recognized debt liability as a direct deduction from the carrying value of that associated debt, consistent with the presentation of a debt discount. The update does not impact the measurement or recognition of debt issuance costs. As of April 3, 2016, debt issuance costs are $76 million and are presented as contra-liabilities to Short-term borrowings, including current portion of long-term debt ($1 million) and Long-term debt ($75 million). In the December 31, 2015 condensed consolidated balance sheet, we have reclassified debt issuance costs of $79 million ($1 million from Other current assets and $79 million from Other noncurrent assets) and have presented them as contra-liabilities to Short-term borrowings, including current portion of long-term debt ($1 million) and Long-term debt ($79 million) to conform to the current period presentation.
[4] As of April 3, 2016, derivative instruments at fair value include interest rate swaps ($5 million), foreign currency swaps ($454 million) and foreign currency forward-exchange contracts ($403 million) and, as of December 31, 2015, include interest rate swaps ($5 million), foreign currency swaps ($560 million) and foreign currency forward-exchange contracts ($80 million).
[5] As of April 3, 2016, derivative instruments at fair value include interest rate swaps ($4 million), foreign currency swaps ($857 million) and foreign currency forward-exchange contracts ($29 million) and, as of December 31, 2015, include interest rate swaps ($134 million), foreign currency swaps ($928 million) and foreign currency forward-exchange contracts ($1 million).